Steven Ray Stoltz, MD
Clinical Professor of Medicine, UCSF
Hospitalist Division Director
Cedars-Sinai Medical Center
|Board Certified:||Internal Medicine|
|Awards and Recognition:||
1986 University of California, Berkeley - Chemistry Honors Society
2009 Kaiser Award for Excellence in Teaching Nomination; UCSF Fresno
Stoltz S. Taking teaching skills to Laos. Internal Medicine News 2010;43:56.
Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial. Lancet Neurol 2014;13:1177-85. Epub 2014 Oct 23. PubMed PMID: 25453457; PubMed Central PMCID: PMC4284947.
I am currently the local PI (principal investigator) as part of a multicenter trial looking at the use of an oral nutritional supplement in older hospitalized patients with heart failure, pneumonia, chronic obstructive pulmonary disease or myocardial infarction in readmission rates. In addition, I will soon be the local PI as part of a multicenter, phase II trial looking at new treatment for hospitalized influenza patients.
I also participated as the site physician in charge of blood pressure monitoring for the SPS3 study (Secondary Prevention of SmallSubcortical Strokes). The SPS3 study was a NIH-sponsored, international, multi-center study intended to define efficacious therapies for the prevention of stroke recurrence and cognitive decline in patients with symptomatic small subcorticalstroke/subcortical transient ischemic attacks. My role in this study, in conjunction with the Division of Neurology at UCSF Fresno, was to review and monitor the blood pressures of patients who were enrolled in the trial at the UCSF Fresno site.